Luca Rinaldi

7.8k total citations · 6 hit papers
155 papers, 4.5k citations indexed

About

Luca Rinaldi is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Luca Rinaldi has authored 155 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 46 papers in Hepatology and 38 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Luca Rinaldi's work include Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (30 papers) and Diabetes Treatment and Management (19 papers). Luca Rinaldi is often cited by papers focused on Liver Disease Diagnosis and Treatment (49 papers), Hepatitis C virus research (30 papers) and Diabetes Treatment and Management (19 papers). Luca Rinaldi collaborates with scholars based in Italy, United States and United Kingdom. Luca Rinaldi's co-authors include Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Raffaele Marfella, Pia Clara Pafundi, Riccardo Nevola, Erica Vetrano and Aldo Marrone and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Luca Rinaldi

145 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications

2023 270 citations Alfredo Caturano, Vincenzo Russo et al. profile →
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives

2023 161 citations Riccardo Nevola, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

2022 152 citations Teresa Salvatore, Raffaele Galiero et al. International Journal of Molecular Sciences profile →
Predictors of early and late hepatocellular carcinoma recurrence

2023 102 citations Riccardo Nevola, Domenico Cozzolino et al. profile →
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options

2023 89 citations Raffaele Galiero, Alfredo Caturano et al. International Journal of Molecular Sciences profile →
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications

2025 40 citations Alfredo Caturano, Maria Rocco et al. Antioxidants profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Luca Rinaldi	1.7k	1.3k	1.1k	1.0k	650	155	4.5k
Chengfu Xu	2.5k 1.5×	1.0k 0.8×	684 0.6×	1.1k 1.0×	358 0.6×	183	4.9k
Ferdinando Carlo Sasso	1.6k 1.0×	2.4k 1.8×	599 0.6×	1.9k 1.9×	1.7k 2.7×	178	6.7k
Byung‐Wan Lee	2.6k 1.5×	2.6k 2.0×	619 0.6×	1.5k 1.5×	929 1.4×	278	6.9k
Lory Saveria Crocè	3.3k 1.9×	1.0k 0.8×	1.8k 1.7×	807 0.8×	269 0.4×	104	4.7k
Roberto Testa	2.4k 1.4×	1.7k 1.3×	1.7k 1.6×	1.5k 1.5×	1.6k 2.5×	238	8.3k
Kathleen E. Corey	4.8k 2.8×	1.9k 1.4×	2.5k 2.3×	962 0.9×	734 1.1×	167	7.0k
Bilal Hameed	4.1k 2.4×	1.3k 1.0×	2.5k 2.3×	857 0.8×	325 0.5×	70	5.7k
Mariana Verdelho Machado	4.9k 2.9×	1.9k 1.4×	1.8k 1.7×	2.1k 2.0×	445 0.7×	90	6.7k
Daniel Q. Huang	4.8k 2.8×	1.3k 1.0×	2.8k 2.7×	1.0k 1.0×	384 0.6×	180	7.1k
Marcello Persico	4.3k 2.5×	987 0.8×	3.3k 3.1×	716 0.7×	301 0.5×	204	6.5k

Countries citing papers authored by Luca Rinaldi

Since Specialization

Citations

This map shows the geographic impact of Luca Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Rinaldi more than expected).

Fields of papers citing papers by Luca Rinaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Rinaldi. The network helps show where Luca Rinaldi may publish in the future.

Co-authorship network of co-authors of Luca Rinaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Rinaldi. A scholar is included among the top collaborators of Luca Rinaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Rinaldi. Luca Rinaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caturano, Alfredo, Enes Erul, Vincenzo Russo, et al.. (2025). Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad. European Journal of Clinical Investigation. 56(1). e70132–e70132.

Caturano, Alfredo, Maria Rocco, Giovanni Di Lorenzo, et al.. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants. 14(1). 72–72. 40 indexed citations breakdown →

Caturano, Alfredo, Giovanni Di Lorenzo, Maria Rocco, et al.. (2025). Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm. Reviews in Cardiovascular Medicine. 26(11). 43143–43143.

Adinolfi, Luigi Elio, Aldo Marrone, Luca Rinaldi, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management. Exploration of Medicine. 5 indexed citations

Vetrano, Erica, Raffaele Galiero, Vittorio Simeon, et al.. (2025). Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals. 18(8). 1200–1200.

Gatti, Daniele, et al.. (2024). On humans' (explicit) intuitions about the meaning of novel words. Cognition. 251. 105882–105882.

Caturano, Alfredo, Erica Vetrano, Raffaele Galiero, et al.. (2024). Advances in the Insulin–Heart Axis: Current Therapies and Future Directions. International Journal of Molecular Sciences. 25(18). 10173–10173. 7 indexed citations

Caturano, Alfredo, Raffaele Galiero, Erica Vetrano, et al.. (2024). Insulin–Heart Axis: Bridging Physiology to Insulin Resistance. International Journal of Molecular Sciences. 25(15). 8369–8369. 19 indexed citations

Caturano, Alfredo, Gaetano Vaudo, Vincenzo Russo, et al.. (2024). Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions. SHILAP Revista de lepidopterología. 6(1). 214–229. 4 indexed citations

10.

Caturano, Alfredo, Vincenzo Russo, Raffaele Galiero, et al.. (2024). Advances in Nanomedicine for Precision Insulin Delivery. Pharmaceuticals. 17(7). 945–945. 16 indexed citations

11.

Caturano, Alfredo, Raffaele Galiero, Maria Rocco, et al.. (2024). The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease. Biomolecules. 14(11). 1393–1393. 6 indexed citations

12.

Cozzolino, Domenico, Ciro Romano, Celestino Sardu, et al.. (2023). Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome. Journal of Clinical Medicine. 12(17). 5691–5691. 1 indexed citations

13.

Caturano, Alfredo, Raffaele Galiero, Giuseppe Loffredo, et al.. (2023). Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study. Biomedicines. 11(2). 322–322. 30 indexed citations

14.

Caturano, Alfredo, Gaetana Albanese, Anna Di Martino, et al.. (2023). Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study. Biomedicines. 11(10). 2866–2866. 3 indexed citations

15.

Dell’Annunziata, Federica, Rosa Giugliano, Annalisa Chianese, et al.. (2022). Pulsed laser ablation of magnetic nanoparticles as a novel antibacterial strategy against gram positive bacteria. Applied Surface Science Advances. 7. 100213–100213. 17 indexed citations

16.

Berretta, Massimiliano, Vincenzo Quagliariello, Alessia Bignucolo, et al.. (2022). The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies. Antioxidants. 11(6). 1090–1090. 22 indexed citations

17.

Pafundi, Pia Clara, Carlo Garofalo, Raffaele Galiero, et al.. (2021). Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects. Diagnostics. 11(2). 290–290. 23 indexed citations

18.

Palmiero, Giuseppe, Arturo Cesaro, Erica Vetrano, et al.. (2021). Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. International Journal of Molecular Sciences. 22(11). 5863–5863. 71 indexed citations

19.

Mencagli, Gabriele, et al.. (2021). WindFlow: High-Speed Continuous Stream Processing With Parallel Building Blocks. IEEE Transactions on Parallel and Distributed Systems. 32(11). 2748–2763. 13 indexed citations

20.

Lombardi, Rosa, Lorena Airaghi, Giovanni Targher, et al.. (2019). Liver fibrosis by FibroScan^® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes. Liver International. 40(2). 347–354. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact